|
Real-time Estimate
Cboe Europe
15:11:58 29/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 17.68 SEK | 0.00% |
|
-1.12% | -21.68% |
Company Valuation: SynAct Pharma AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,703 | 2,416 | 314.1 | 416.8 | 1,205 | 990 | - | - |
| Change | - | -34.75% | -87% | 32.69% | 189.2% | -17.86% | - | - |
| Enterprise Value (EV) 1 | 3,703 | 2,416 | 314.1 | 370 | 1,152 | 1,015 | 1,064 | 990 |
| Change | - | -34.75% | -87% | 17.8% | 211.31% | -11.89% | 4.87% | -6.97% |
| P/E | -53.1x | -22.6x | -1.33x | -4.31x | -10.4x | -10.5x | -18x | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0.7x | -0x | 0.1x | -2.4x | 0.5x | 0.4x | - |
| Capitalization / Revenue | - | - | - | - | - | 22.4x | 45.8x | 12.7x |
| EV / Revenue | - | - | - | - | - | 22.9x | 49.3x | 12.7x |
| EV / EBITDA | - | - | -1.4x | -4.11x | -9.88x | -21.4x | -32.1x | 34.7x |
| EV / EBIT | - | - | -1.4x | -4.11x | -9.88x | -21.3x | -32x | 34.7x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.68 | -3.6 | -6.64 | -2.08 | -2.17 | -1.68 | -0.98 | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | 44.25 | 21.6 | 77.9 |
| EBITDA 1 | - | - | -224.5 | -89.98 | -116.5 | -47.49 | -33.16 | 28.5 |
| EBIT 1 | - | - | -224.5 | -89.98 | -116.5 | -47.75 | -33.29 | 28.5 |
| Net income 1 | -69.3 | -99.2 | -215.8 | -82.4 | -110.8 | -47.08 | -31.92 | 28.5 |
| Net Debt 1 | - | - | - | -46.75 | -53.41 | 24.81 | 74.22 | - |
| Reference price 2 | 142.40 | 81.50 | 8.83 | 8.96 | 22.60 | 17.68 | 17.68 | 17.68 |
| Nbr of stocks (in thousands) | 26,006 | 29,648 | 35,571 | 46,487 | 53,330 | 55,998 | - | - |
| Announcement Date | 11/02/22 | 17/02/23 | 23/02/24 | 18/02/25 | 18/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.52x | 22.93x | -21.37x | - | 99.42M | |
| 33.68x | 12.2x | 24.79x | 0.59% | 1,056B | |
| 30.25x | 6.73x | 18.83x | 1.97% | 655B | |
| 33.7x | 7.87x | 16.27x | 2.61% | 471B | |
| 19.34x | 4.71x | 11.68x | 2.82% | 342B | |
| 20.6x | 5.35x | 13.29x | 2.98% | 277B | |
| 21.11x | 4.38x | 12.46x | 2.02% | 257B | |
| 26.41x | 6.87x | 12.24x | 2.41% | 226B | |
| -46.04x | 6.69x | 26.14x | 2.16% | 189B | |
| 11.29x | 4.12x | 8.55x | 4.45% | 170B | |
| Average | 13.98x | 8.19x | 12.29x | 2.45% | 364.3B | |
| Weighted average by Cap. | 24.21x | 7.89x | 18.18x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SYNACT Stock
- Valuation SynAct Pharma AB
Select your edition
All financial news and data tailored to specific country editions
